Cargando…

May bullous pemphigoid be worsened by COVID-19 vaccine?

Detalles Bibliográficos
Autores principales:	Cozzani, Emanuele, Gasparini, Giulia, Russo, Roberto, Parodi, Aurora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663456/ https://www.ncbi.nlm.nih.gov/pubmed/36388909 http://dx.doi.org/10.3389/fmed.2022.931872

Ejemplares similares

Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study
por: Maronese, Carlo Alberto, et al.
Publicado: (2022)

Use of Dupilumab in Bullous Pemphigoid: Where Are We Now?
por: Russo, Roberto, et al.
Publicado: (2022)

Absolving COVID-19 Vaccination of Autoimmune Bullous Disease Onset
por: Russo, Roberto, et al.
Publicado: (2022)

Self‐resolving bullous pemphigoid induced by cemiplimab
por: Molle, Mattia Fabio, et al.
Publicado: (2022)

Targeting interleukin 4 receptor α: A new approach to the treatment of cutaneous autoimmune bullous diseases?
por: Russo, Roberto, et al.
Publicado: (2020)

Intravenous immunoglobulins in infantile dyshidrosiform bullous pemphigoid refractory to steroids and dapsone
por: Viglizzo, Gianmaria, et al.
Publicado: (2022)

Guselkumab‐associated bullous pemphigoid in a psoriasis patient: A case report and review of the literature
por: Burlando, Martina, et al.
Publicado: (2021)

Pilot study investigating BP-180 in extracellular vesicles derived from blister fluid of bullous pemphigoid patients
por: Gasparini, Giulia, et al.
Publicado: (2023)

Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study
por: Kasperkiewicz, Michael, et al.
Publicado: (2022)

Bullous pemphigoid and COVID-19 vaccine()
por: Pérez-López, Israel, et al.
Publicado: (2021)

Response: Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study
por: Pira, Anna, et al.
Publicado: (2023)

New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update
por: Genovese, Giovanni, et al.
Publicado: (2019)

Bullous Pemphigoid Complicated by Sepsis
por: Shah, Dipal, et al.
Publicado: (2022)

Editorial: Autoimmune blistering diseases: advances in the understanding of pathogenesis and new therapeutic horizons
por: Gasparini, Giulia, et al.
Publicado: (2023)

Case Report: Infantile Bullous Pemphigoid: Triggering by COVID-19 Is Speculative
por: Rosińska-Więckowicz, Anna, et al.
Publicado: (2021)

Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?
por: Parodi, Aurora, et al.
Publicado: (2020)

Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination
por: Shanshal, Mohammed
Publicado: (2022)

The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets
por: Maglie, Roberto, et al.
Publicado: (2023)

New‐onset bullous pemphigoid and flare of pre‐existing bullous pemphigoid after the third dose of the COVID‐19 vaccine
por: Bardazzi, Federico, et al.
Publicado: (2022)

Chilblain-like Lesions after COVID-19 Vaccination: A Case Series
por: RUSSO, Roberto, et al.
Publicado: (2022)

Considerations on SARS-CoV-2 vaccines in patients with autoimmune blistering diseases
por: Cozzani, Emanuele, et al.
Publicado: (2021)

The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations
por: Kridin, Khalaf, et al.
Publicado: (2018)

Bullous pemphigoid
por: Miyamoto, Denise, et al.
Publicado: (2019)

Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine
por: Agharbi, F.-Z., et al.
Publicado: (2022)

Bullous pemphigoid following COVID-19 vaccine: An autoimmune disorder
por: Aashish, et al.
Publicado: (2022)

Comorbidities and Treatment Strategies in Bullous Pemphigoid: An Appraisal of the Existing Litterature
por: Bech, Rikke, et al.
Publicado: (2018)

Bullous Pemphigoid and Other Pemphigoid Dermatoses
por: Pratasava, Valeryia, et al.
Publicado: (2021)

Case report: bullous pemphigoid development underlies dystrophic epidermolysis bullosa disease worsening
por: Di Zenzo, Giovanni, et al.
Publicado: (2022)

Bullous Pemphigoid Presenting with Esophagitis Dissecans Superficialis
por: Inoue, Kunimitsu, et al.
Publicado: (2017)

Bullous Pemphigoid in a Patient Treated with Pembrolizumab
por: Hara, Kanako, et al.
Publicado: (2019)

Paraneoplastic Wong-Type Dermatomyositis Associated with Gynecological Malignancy
por: Russo, Roberto, et al.
Publicado: (2022)

Considerations on inhibition of IL‐23 in psoriatic women of childbearing potential
por: Russo, Roberto, et al.
Publicado: (2021)

Alterations of Total Serum Immunoglobulin Concentrations in Pemphigus and Pemphigoid: Selected IgG2 Deficiency in Bullous Pemphigoid
por: Khil'chenko, Stanislav, et al.
Publicado: (2020)

Covid-19-vaccine/vildagliptin interaction: Bullous pemphigoid: case report
Publicado: (2022)

Esophageal Bullous Pemphigoid
por: Castelo Branco, Catarina, et al.
Publicado: (2022)

Resolution in bullous pemphigoid
por: Sadik, Christian D., et al.
Publicado: (2019)

Dyshidrosiform Bullous Pemphigoid
por: Cohen, Philip R.
Publicado: (2021)

When Bullous Pemphigoid Is Not Bullous Pemphigoid: The Importance of Going Beyond Direct Immunofluorescence
por: Hopkins, Christina R, et al.
Publicado: (2022)

Cutaneous Dermatophytosis Mimicking Bullous Pemphigoid or Typical Bullous Pemphigoid and Tinea Incognito?
por: Andrés, Tirado-Sánchez, et al.
Publicado: (2019)

A 50-year-old female with bullous pemphigoid
por: Wanjari, Mayur, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qfg8n7bdjk7rfddnmaqkaovr8s